Zoetis.co.uk uses cookies to improve your experience when browsing our website. By continuing to use this site, you are agreeing to their use. To find out more, view our cookie policy.

United Kingdom

Research and Development

Research and Development

Zoetis is focused on continuously innovating to develop animal health solutions that meet the needs of those who raise and care for animals. R&D is at the core of our efforts to provide innovation outcomes that anticipate the future needs of veterinary surgeons and livestock producers in their local markets around the globe.

Our researchers and scientists worldwide work to broaden and enhance our existing range of products by adding new species or claims, securing approvals in additional countries, or creating new combinations and reformulations so that more customers can benefit from our animal health solutions. New product R&D leverages discoveries of agribusiness, pharmaceutical and biotechnology R&D. Our ability to leverage both the discoveries of other industries and of our existing R&D generally yields a faster, less expensive and more predictable R&D process and a more sustainable R&D pipeline as compared to human health.

R&D Areas of Focus

Our research is fuelled by both innovation within Zoetis and collaboration with external partners. We apply our research to a broad and diverse range of species, therapeutic areas and geographic regions, and our research encompasses vaccines, medicines, genetic products, diagnostics and biodevices.

R&D Capabilities

Expertise

The Zoetis R&D organisation is comprised of scientific experts across numerous disciplines in science and veterinary medicine. These experts use state-of-the-art research facilities, the latest technologies and innovative approaches to deliver complete health solutions to veterinary surgeons and livestock farmers.

Operations Worldwide

In addition to our global R&D headquarters in Kalamazoo, Michigan, the Zoetis research network includes R&D teams throughout the U.S. (California, Iowa, Maryland, Missouri, Nebraska, New Jersey and North Carolina), Canada, Europe (Belgium, France and Spain), Australia, and in key emerging markets (Brazil, India and China).

This worldwide network allows us to listen to livestock producers and veterinary surgeons, region by region, and translate their challenges into practical and cost-effective innovations tailored to meet their needs. Our regional footprint is at the core of our ability to respond rapidly and accurately when emerging infectious diseases spread and threaten the lives of people, animals and livelihoods.